taking too much tirzepatide This study is really interesting because it moves us closer to the idea that obesity is not one single disease — and that someday we may match treatments to a person's What Happens if You Take

Both remain in phase 3 clinical development programs [16]: Cagrilintide Status: Phase 3 trials ongoing for CagriSema (cagrilintide + semaglutide combination) Expected approval timeline: 2027-2028 for the combination product Monotherapy development pathway unclear Retatrutide Status: Phase 3 trials initiated in 2024-2025 Monotherapy development for obesity and metabolic dysfunction Expected approval timeline: 2028-2029 if trials succeed This regulatory status means any use of these compounds, whether individually or in cagrilintide dosage with retatrutide combinations, occurs in research contexts or through off-label prescribing once (if) individual approvals are obtained

Causes and risk factors There are several possible reasons why someone may experience heart palpitations while taking Ozempic

10

Slower Gastric Emptying: Mounjaro slows down how quickly food leaves your stomach, contributing to a prolonged feeling of fullness

Patients should maintain a symptom diary documenting when breathlessness occurs, its severity, associated activities, and any relieving or exacerbating factors

Mahajan, A